Drug Shortage Report for RESONIUM CALCIUM

Last updated on 2024-02-23 History
Report ID 208624
Drug Identification Number 02017741
Brand name RESONIUM CALCIUM
Common or Proper name Resonium Calcium
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) CALCIUM POLYSTYRENE SULFONATE
Strength(s) 999MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration RECTAL ORAL RECTAL ORAL
Packaging size 1
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-10-26
Estimated end date 2024-02-23
Actual end date 2024-02-22
Shortage status Resolved
Updated date 2024-02-23
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-02-23 French Compare
v9 2024-02-23 English Compare
v8 2024-02-05 French Compare
v7 2024-02-05 English Compare
v6 2024-01-12 French Compare
v5 2024-01-12 English Compare
v4 2023-12-01 French Compare
v3 2023-12-01 English Compare
v2 2023-10-30 French Compare
v1 2023-10-30 English Compare

Showing 1 to 10 of 10